$22.87

-0.68 (-2.89%)

Weekly Expected Move ±6.5%

$20 $21 $23 $24 $26

NYSE · Healthcare · Biotechnology · Alpha Radar Neutral · Power 40 · $323.9M mcap · 14M float · 2.48% daily turnover · Short 81% of daily vol

Revenue

$13M +85.7% ▲

Gross Profit

$12M +103.2% ▲

Operating Income

-$81M -15.8% ▼

Net Income

-$69M -3.1% ▼

EPS (Diluted)

$-2.18 +4.0% ▲

EBITDA

-$80M -21.7% ▼

View Full Income Statement

Line Item	FY2023	FY2024	FY2025
Revenue	$5M	$7M	$13M
YoY Growth	+0.0%	+40.0%	+85.7%
Cost of Revenue	$1M	$1M	$1M
Gross Profit	$4M	$6M	$12M
Gross Margin	80.0%	81.6%	89.3%
R&D Expenses	$32M	$64M	$74M
SG&A Expenses	$10M	$11M	$19M
Operating Expenses	$42M	$76M	$93M
Operating Income	-$38M	-$70M	-$81M
Operating Margin	-757.0%	-1000.2%	-623.6%
Interest Expense	$58K	$34K	$7K
Income Before Tax	-$34M	-$67M	-$69M
Tax Expense	$0	$0	$0
Net Income	-$34M	-$67M	-$69M
Net Margin	-681.1%	-954.4%	-529.8%
EPS (Diluted)	$-1.13	$-2.27	$-2.18
EBITDA	-$33M	-$65M	-$80M
Shares Outstanding	30M	30M	32M

Line Item	FY2024 Q1	FY2024 Q2	FY2024 Q4	FY2025 Q1	FY2025 Q2	FY2025 Q3	FY2025 Q4	FY2026 Q1
Revenue	$7M	$0	$0	$3M	$0	$10M	$0	$0
Cost of Revenue	$271K	$325K	$0	$377K	$375K	$311K	$0	$349K
Gross Profit	$7M	-$325K	$0	$3M	-$375K	$10M	$0	-$349K
Gross Margin	96.1%	—	—	87.4%	—	96.9%	—	—
R&D Expenses	$8M	$25M	$16M	$14M	$20M	$20M	$20M	$17M
SG&A Expenses	$3M	$3M	$3M	$3M	$3M	$3M	$9M	$6M
Operating Expenses	$10M	$28M	$19M	$18M	$23M	$23M	$30M	$24M
Operating Income	-$4M	-$28M	-$19M	-$15M	-$23M	-$13M	-$30M	-$24M
Operating Margin	-53.6%	—	—	-501.1%	—	-133.3%	—	—
Interest Expense	$11K	$9K	$0	$4K	$3K	$0	$0	$0
Income Before Tax	-$3M	-$27M	-$18M	-$15M	-$14M	-$12M	-$28M	-$22M
Tax Expense	$0	$0	$0	$0	$0	$0	$0	$0
Net Income	-$3M	-$27M	-$18M	-$15M	-$14M	-$12M	-$28M	-$22M
Net Margin	-39.8%	—	—	-485.2%	—	-124.8%	—	—
EPS (Diluted)	$-0.09	$-0.91	$-1.47	$-0.48	$-0.45	$-0.40	$-0.90	$-0.64
EBITDA	-$3M	-$27M	-$19M	-$14M	-$13M	-$12M	-$29M	-$24M
Shares Outstanding	30M	30M	13M	30M	30M	32M	32M	34M

EVMN NYSE